Liquidia Corporation Common Stock vs Envista Holdings Corporation Common Stock — how do they compare? Liquidia Corporation Common Stock trades at $33.69 (market cap $3.04B), while Envista Holdings Corporation Common Stock trades at $22.57 (market cap $3.67B). The key difference: Envista Holdings Corporation Common Stock is the larger of the two by market cap, and Envista Holdings Corporation Common Stock is trading nearer its 52-week high, Liquidia Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Envista Holdings Corporation Common Stock for 0 Days on average.
| LQDA | NVST | |
|---|---|---|
Market Cap | $3.04B | $3.67B |
Volume | 21,111,778 | 1,988,435 |
Sector | Health | Health |
52-Week High | $91.03 | $30.26 |
52-Week Low | $22.02 | $18.95 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.94B | $4.13B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →Envista Holdings Corporation is a global dental products company that develops, manufactures, and markets dental implants, orthodontic systems, and other consumables and equipment for dental professionals worldwide.
Read more on NVST →